Cancer research

RNA Vaccines Increase and Activate T Cells in the Brain to Improve Cell Therapy for Glioblastoma

Updated

Abstract

Delivery of mRNA encoding the ovalbumin epitope SIINFEKL led to expansion of ovalbumin-specific OT1 CD8+ T cells to up to 80% of all circulating CD8+ T cells.

  • Adoptive T cell therapy has limited effectiveness against solid tumors like brain tumors due to challenges in accessing target antigens.
  • Using an mRNA vaccine to encode the target antigen can enhance the restimulation and persistence of transferred TCR-T cells.
  • RNA vaccination significantly improved T cell infiltration in the brain and maintained an active immune response, which suppressed glioblastoma growth.
  • In an experimental model, co-administration of dendritic cells with PTPRZ1-mRNA resulted in successful rejection of human gliomas expressing the target antigen.
  • These results indicate that mRNA vaccines may effectively enhance TCR-T cell therapy for glioblastoma.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free